Pagar Swati Appasaheb, Shinkar Dattatraya Manohar, Saudagar Ravindra Bhanudas
tlooto Summary
The nasal delivery seems to be a favorable way to circumvent the obstacles for blood-brain barrier allowing the direct drug delivery in the biophase of central nervous system (CNS) active compounds.
Abstract
INTRODUCTION The history of nasal drug delivery dates back to earlier topical applications of drugs intended for local effects. Nasal therapy also called ‘Nasya karma’ has been recognized form of treatment in the Ayurvedic system of Indian medicines [1]. The early 1980s saw the introduction of nasal route as a promising systemic delivery alternative to other conventional drug delivery routes [2]. Nasal route is easily accessible, convenient, and a reliable with a porous endothelial membrane and a highly vascularized epithelium that provides a rapid absorption of compounds into the systemic circulation, avoiding the hepatic first pass elimination. In addition, intranasal drug delivery enables dose reduction, rapid attainment of therapeutic blood levels, quicker onset of pharmacological activity, and fewer side effects [3, 4]. The low metabolic environment of nose has potential to overcome the limitation of oral route and duplicate the benefit of intravenous administration. In addition to that, nasal administration minimizes the lag time associated with oral drug delivery and offers noninvasiveness, self-administration, patient comfort, and patient compliance, which are the hurdles in intravenous drug therapy. [5] It was reported that lipophilic drugs are generally well absorbed from the nasal cavity with pharmacokinetic profiles, which are often identical to those obtained after an intravenous injection with a bioavailability approaching 100% [1], on the other hand absorption of hydrophilic drugs can be increased by means of absorption enhancers. [2] Drugs ranging from small chemicals to large macromolecules including peptide/protein therapeutics, hormones, and vaccines, are being delivered through the nasal cavity [6]. The nasal delivery seems to be a favorable way to circumvent the obstacles for blood-brain barrier (BBB) allowing the direct drug delivery in the biophase of central nervous system (CNS) active compounds. It has also been considered to the administration of vaccines [78]. Buserelin, desmopressin, calcitonin, insulin, luteinizing hormone releasing hormone, growth hormone and adreno-corticotrophic hormone are some of the peptides that have been successfully administered through the nasal route. Apart from these, steroids (corticosteroids, estradiol, progesterone, testosterone, and so on) [9, 10] antihypertensives (nifedipine, nitroglycerine, propranolol, hydralazine, and so on), analgesics Review Article
Citation format
APPASAHEB, Pagar Swati; MANOHAR, Shinkar Dattatraya; BHANUDAS, Saudagar Ravindra. A review on intranasal drug delivery system. Journal of Advanced Pharmacy Education and Research, 2013.